#treatment — Sunday, March 01, 2026 (1 items)
| 0 | 💬 0 |
A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China.
(linkinghub.elsevier.com)
|
Clinical Microbiology and Infection 2026-03-01 | #infection #amr #treatment #tb |